A Study to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity of EQ001 in Subjects With aGVHD

Clinical trial NCT03763318 · COMPLETED

Trial details

NCT number: NCT03763318
Sponsor: Biocon Limited
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute-graft-versus-host Disease aGVHD GVHD GVHD, Acute

Start date: 2019-07-15
Primary completion: 2022-11-21
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.